1Andrews TC,Ballantyne CM,Hsia JA,et al.Achieving and maintaining national cholesterol education program low-density lipoprotein choles-terol goals with five statins.Am J Med,2001,11:185-189. 被引量：1
2Jones P,Kafonejk S,Laurora L,et al.Comparative dose efficacy study of atorvastatin versus simvastatin,pravastatin,lovastatin and fluvastatin in patients with hypercholesterolem in the CURVES study.Am J Cardiol,1998,81:528-587. 被引量：1
6Kanadasi M, Cayli M, Demirtas M, et al. The effect of early statin treatment on inflammation and cardiac events in acute coronary syn- drome patients with low-density lipoprotein cholesterol [J]. Heart Vessels, 2006, 21(5): 291-297. 被引量：1
7Yeghiaz~rians Y, Braunstein JB, Askari A, et al. Unstable angina pectofis [J]. N Engl J Med, 2000, 342(2): 101-114. 被引量：1
8Roensch J, Crisby M, Nordberg A, et al. Effects of statins on alpha7 nicotinic receptor, cholinesterase and alpha-form of secreted amy- loid precursor peptide in SH-SY5Y cells [J]. Neurochem Int, 2007, 50(6): 800-806. 被引量：1
9Pedersen TR, Cater NB, Faergeman O, et al. Comparison of atorvas- tatin 80 mg/day versus simvastatin 20 to 40 mg/day on frequency of cardiovascular events late (five years) after acute myocardial in- farction (from the Incremental Decrease in End Points through Ag- gressive Lipid Lowering [IDEAL] trial [J]. Am J Cardiol, 2010, 106 (3): 354-359. 被引量：1
10Cho E J, Min Y J, Oh MS, et al. Disappearance of angina pectoris by lipid-lowering in type Ⅲ hyperlipoproteinemia [J]. Am J Cardiol, 2011, 107(5): 793-796. 被引量：1
